Jessica Buddenbaum

ORCID: 0000-0002-4870-7131
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hematopoietic Stem Cell Transplantation
  • Polyomavirus and related diseases
  • Immune Cell Function and Interaction
  • Acute Lymphoblastic Leukemia research

Johns Hopkins Medicine
2016

Johns Hopkins University
2016

Lower-intensity conditioning regimens for haploidentical blood or marrow transplantation (BMT) are safe and efficacious adult patients with hematologic malignancies. We report data pediatric/young high-risk malignancies (n = 40) treated nonmyeloablative BMT post-transplantation cyclophosphamide from 2003 to 2015. Patients received a preparative regimen of fludarabine, cyclophosphamide, total body irradiation. Post-transplantation immunosuppression consisted mycophenolate mofetil, tacrolimus....

10.1016/j.bbmt.2016.11.016 article EN cc-by-nc-nd Biology of Blood and Marrow Transplantation 2016-11-22

Lower intensity conditioning regimens for haploidentical blood or marrow transplantation (BMT) have been demonstrated to be safe and efficacious adult patients with hematologic malignancies. We report the first data pediatric/young high-risk malignancies (n=40) enrolled on (n=28), treated according (n=12), IRB-approved clinical trials of nonmyeloablative BMT post-transplantation cyclophosphamide (PT/Cy) from 2003-2015. The majority (n=36) received a preparative regimen IV fludarabine (30...

10.1016/j.bbmt.2015.11.399 article EN cc-by-nc-nd Biology of Blood and Marrow Transplantation 2016-02-18
Coming Soon ...